US-based Thyme Companies has announced the launch of biosimilars venture Thyme Therapeutics to establish a new sustainable approach to the commercialization of oncology products.
US-based Thyme Companies has announced the launch of biosimilars venture Thyme Therapeutics to establish a new sustainable approach to the commercialization of oncology products.